Skip to content
healthcare.dev

Xofluza

NDC 85766-058, BALOXAVIR MARBOXIL, tablet, film coated, from Sportpharm LLC.

Product NDC
85766-058
Status
Listed
Labeler
Sportpharm LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210854
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85766-058 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BALOXAVIR MARBOXIL80 mg/1

Pharmacologic classes

Chelating Activity [MoA]; Polymerase Acidic Endonuclease Inhibitor [EPC]; Polymerase Acidic Endonuclease Inhibitors [MoA]

Package NDCNDC-11Package
85766-058-01857660058011 BLISTER PACK in 1 CARTON (85766-058-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b58b2899-4d22-41e1-8f0c-bdead8917694

Use it

Look up 85766-058 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85766-058 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85766-058. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.